Wynia, K., Roodbol, P.F., Middel, B.
People with Multiple Sclerosis (MS) perceive consequences of this chronic condition that are not limited to impairments in physical functioning but also have their impact on limitations in activities...
Oeseburg, B., Wynia, K., Middel, B., Reijneveld, S.A.
Background: Financial constraints and quality requirements demand that interventions selected are most effective. A previous systematic review of the effectiveness of the patient advocacy case...
Wessels, H., De Graeff, A., Wynia, K., Sixma, H. J., De Heus, M., Schipper, M., ...
Background: To improve quality of care for cancer patients, it is important to have an insight on the patient's view on health care and on their specific wishes, needs and preferences, without...
Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP) (2008)
Wynia, K., Middel, B., De Ruiter, H., Van Dijk, J.P., Reijneveld, S.A.
Objective. To examine the stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP) in criterion-related groups. The MSIP is a disease-targeted health impact measure based on a...
The impact of disabilities on quality of life in people with multiple sclerosis (2008)
Wynia, K., Middel, B., Van Dijk, J.P., De Keyser, J.H., Reijneveld, S.A.
Objective People with Multiple Sclerosis (MS) experience lower levels of quality of life (QOL) than people from the general population. We examined the relative impact of MS-related disabilities on...
The impact of disabilities on quality of life in people with multiple sclerosis (2008)
Wynia, K., Middel, B., Van Dijk, J.P., De Keyser, J.H., Reijneveld, S.A.
Objective People with Multiple Sclerosis (MS) experience lower levels of quality of life (QOL) than people from the general population. We examined the relative impact of MS-related disabilities on...
Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP) (2008)
Wynia, K., Middel, B., De Ruiter, H., Van Dijk, J.P., Reijneveld, S.A.
Objective. To examine the stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP) in criterion-related groups. The MSIP is a disease-targeted health impact measure based on a...
Bosma, R., Wynia, K., Havlikova, E., De Keyser, J., Middel, B.
OBJECTIVES: The current review evaluates the safety and efficacy of desmopressin in patients with multiple sclerosis (MS) who suffer from both daytime and nocturnal voiding frequency and from...
Bosma, R., Wynia, K., Havlikova, E., De Keyser, J., Middel, B.
OBJECTIVES: The current review evaluates the safety and efficacy of desmopressin in patients with multiple sclerosis (MS) who suffer from both daytime and nocturnal voiding frequency and from...
Zorg voor mensen met multiple sclerose (2003)
Bosma, R., Wynia, K., Tiesinga, L.J., Middel, B., Jongerden, I., Heijnen-Kaales, Y.